About Us
Haltex Therapeutics was incorporated in 2022 to facilitate the collaboration of medical experts, pharmaceutical companies, academia, domain experts and social investors. Haltex Therapeutics has one clear goal: bring a safe and effective therapy against PXE and other ectopic calcifications to market for a price that ensures accessibility for all patients.
The collaboration
Our core team
Antrea Kyriakidou
Regulatory affairs
Cristian Fabbri
Director
Ezequiel Palmiotti
Financial controller
Javier Castorina
Executive director – Pharmaceutical development
Kees Hörchner
Director
Marcos Mosteirin
Operations leader
Vincent van der Wel
Executive director – Clinical development